(Q79772653)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Agnieszka Dansonka-Mieszkowska

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bożena Konopka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Jolanta Kupryjanczyk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

I K Kolasa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A Rembiszewska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A Janiec-Jankowska

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A M Lewandowska

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

21 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

692-697

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

cites work

TP53 and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Hereditary ovarian cancer in Poland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

PTEN: one gene, many syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Pten is essential for embryonic development and tumour suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

PTEN/MMAC1 mutations correlate inversely with an altered p53 tumor suppressor gene in gynecologic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Cooperative translational control of gene expression by Ras and Akt in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Pten dose dictates cancer progression in the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Hypermethylation of the PTEN gene in ovarian cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.007

10.1016/J.YGYNO.2006.05.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16793127%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference